Pelvic inflammatory disease isolates of Neisseria gonorrhoeae are distinguished by C1q-dependent virulence for newborn rats and by the sac-4 region

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2094-2099

  Nowicki, Stella ^a   Ram, Prashanth ^a   Pham, Tuan ^a   Goluszko, Pawel ^a   Morse, Stephen ^b   Anderson, Garland D ^a   Nowicki, Bogdan ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE FREQUENCY; GENETIC RECOMBINATION; GONORRHEA; MICROBIAL GROWTH; NEISSERIA GONORRHOEAE; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT; SEROTYPE;

EID: 0030949244     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2094-2099.1997     Document Type: Article

References (31)

1. Alberti, S., G. Marques, S. Camprubi, S. Merino, J. M. Tomas, F. Vivanco, and V. J. Benedi. 1993. Clq binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun. 61:852-860.
2. Buchan, H., M. Vessey, M. Goldacre, and J. Fairweather. 1993. Morbidity following pelvic inflammatory disease. Br. J. Obstet. Gynecol. 100:558-562.
3. Cannon. J. G., T. J. Lee, L. F. Guymon, and P. F. Sparling. 1981. Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus. Infect. Immun. 32:547-552.
4. Cannon, J. G., T. M. Buchanan, and P. F. Sparling. 1983. Confirmation of association of protein I serotype of Neisseria gonohoea with ability to cause disseminated infection. Infect. Immun. 40:816-819.
5. Department of Health and Human Services and Public Health Services. 1991, Healthy people 2000, p. 496-508. U.S. Department of Health and Human Services and Public Health Services. Washington. D.C.
6. ft. Eisenstein, B. I., and A. T. Masi. 1981. Disseminated gonoeoccal infection (DGI) and gonococcal arthritis (OCA). I. Bacteriology, epidemiology, host factors, pathogen factors, and pathology. Semin. Arthritis Rheum. 10:155-172.
7. Expert Committee on Pelvic Inflammatory Disease. 1991. Pelvic inflammatory disease research directions in the 1990s. Sex. Transm. Dis. l:46-64.
8. N. Harriman, G. R., E. R. Podack. A. I. Braude, L. C. Cornell, A. F. Esser, and J. G. Curd. 1982. Activation of complement by serum-resistant Neisseria gonorrhoeae: assembly of the membrane attack complex without subsequent cell death. J. Exp. Med. 156:1235-1249.
9. Knapp, J. S., E. G. Sandstrom, and K. K. Holmes. 1985. Overview of epidemiological and clinical applications of auxotype/serovar classification of Neisseria gonorrhoeae, p. 6-12. In G. K. Schoolnik. G. F. Brooks, S. Falkow, C. E. Frasch, J. S. Knapp, J. A. McCutchan, and S. A. Morse (ed.), The pathogenic Neisseriae: Proceedings of the Fourth International Symposium. Asilomar, Calif. American Society for Microbiology. Washington, D.C.
10. Mandrell, R. E., A. J. Lesse, J. V. Sugai, M. Shero, J. M. Griffiss, J. A. Cole, N. J. Parsons, H. Smith, S. A. Morse, and M. A. Apicella. 1990. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 17:1649-1664.
11. McCutchan, J. A., D. N. A. Katzanstein, D. N. A. Norquist, G. Chlkami, A. Wunderlich, and A. I. Braude. 1978. Role of blocking antibody in disseminated gonococcal infection. J. Immunol. 121:1884-1888.
12. McShan. W. M., R. P. Williams, and R. A. Hull. 1987. A recombinant molecule from a disseminating strain of Neisseria gonorrhoeae that confers scrum bactericidal resistance. Infect. Immun. 55:3017-3022.
13. Morse, S. A., and K. K. Holmes. 1994. Gonococcal infections, p. 670-685. In P. D. Hoeprich, M. C. Jordan, and A. R. Ronald (ed.), Infectious diseases. J. B. Lippincott Co., Philadelphia, Pa.
14. Nowicki, S. 1991. Possible mechanisms of serum resistance of Neisseria gonorrhoeae from disseminating infections, p. 621-626. In M. Achtman, P. Kohn, C. Marchal, G. Morelli, A. Seiler, and B. Thiesen (ed.), Neisseriae 1990: pathogen-host interactions. Walter de Gruyter, New York, N.Y.
15. Nowicki, S., et al. Unpublished data.
16. 14b.Nowicki, S., et al. U.S. patent O8/532,674 pending.
17. Nowicki, S., B. Nowicki, and M. Martens. 1993. Complement CJq on the surface of gonococcal cells from pelvic inflammatory disease, abstr. 147, p. 125. In Program and Abstracts of the 3rd World Congress for Infectious Diseases. Acapulco, Mexico. International Society for Infections Diseases in Obstetrics and Gynecology, Washington, D.C.
18. Nowicki, S., B. Nowicki, and M. Martens. 1993. Species-dependent attachment of Neisseria gonorrhoeae to the uterus, abstr. 19. Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting, Stowe, Vt.
19. Nowicki, S., B. Nowicki, and M. Martens. 1994. Host factors in the attachment of gonococcal cells to pelvic tissue, p. 292-294. In E. W. Ades, R. F. Rest, and S. A. Morse (ed.), Microbial pathogenesis and immune response. N. Y. Academy of Science, New York, N.Y.
20. Nowicki, S., M. Martens, A. Kaul, and B. Nowicki. 1994. Gonococcal attachment to human ovarian tissue, p. 730-734. In C. J. Conde-Glez, S. Morse, P. Rice, F. Sparling, and E. Calderon (ed.), Pathobiology and immunobiology of Neisseriaceae. National Institute of Public Health, Cuernavaca, Morelos, Mexico.
21. Nowicki, S., M. Martens, and B. Nowicki. 1995. Gonococcal infection in a nonhuman host is determined by human complement Clq. Infect. Immun. 63:4790-4794,
22. Parsons, N. J., P. V. Patel, E. L. Tan, J. R. C. Andrade, C. A. Nairn, M. Goldner, J. A. Cole, and H. Smith. 1988. Cytidine 5′-monophospho-N-acetyl ncuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb. Pathog. 5:303-309.
23. Rice, P. A. 1989. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin. Microbiol. Rev. 2:S112-S117.
24. Rice, P. A., and J. Schachter. 1991. Pathogenesis of pelvic inflammatory disease. What are the questions? JAMA 266:2587-2593.
25. Rice, P. A., W. M. McCormack, and D. L. Kasper. 1980. Natural serum bactericidal activity against Neisseria gonorrheae isolates from disseminated, locally invasive, and uncomplicated disease. J. Immunol. 124:2105-2109.
26. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminnting inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
27. Schoolnik, G. K., T. M. Buchamm, and K. K. Holmes. 1976. Gonococci causing disseminated gonococcal infection arc resistant to the bactericidal action of normal human serum. J. Clin. Invest. 58:1163-1173.
28. So, M., W. S. Dallas, and S. Falkow. 1978. Characterization of an Escherichia coll plasmid encoding for synthesis of heat-labile toxin: molecular cloning of the toxin determinant. Infect. Immun, 21:405-111.
29. Sweet, R. L., M. Blankfort-Doyle, M. O. Robbie, and J. Schachter. 1986. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 255:2062-2064.
30. Washington, A. E., W. Cates, and A. A. Zaidi. 1984. Hospitalizations for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981. JAMA 251:2529-2533.
31. West, S. E. H., and V. L. Clark. 1989. Genetic loci and linkage associations in Neisserin gonorrhoeae and Neisseria meningitidis. Clin. Microbiol. Rev. 2:S92-S103.